First City Capital Management, Inc. Merck & Co., Inc. Transaction History

First City Capital Management, Inc.

$194 Million
Q3 2024

A detailed history of First City Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, First City Capital Management, Inc. holds 24,781 shares of MRK stock, worth $2.43 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

24,781

Previous 26,882 7.82%

Holding current value

$2.43 Million

Previous $3.33 Million 15.42%

% of portfolio

1.45%

Previous 1.9%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$111.15 - $128.97 $233,526 - $270,965	-2,101 Reduced 7.82%	24,781 $2.81 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $164,901 - $177,102	-1,332 Reduced 4.72%	26,882 $3.33 Million
Q1 2024 May 22, 2024	SELL	$113.24 - $131.95 $175,522 - $204,522	-1,550 Reduced 5.21%	28,214 $3.72 Million
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $94,269 - $102,587	-941 Reduced 3.06%	29,764 $3.24 Million
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $5,147 - $5,716	-50 Reduced 0.16%	30,705 $3.16 Million
Q2 2023 Jul 19, 2023	SELL	$108.61 - $118.38 $95,685 - $104,292	-881 Reduced 2.78%	30,755 $3.55 Million
Q1 2023 May 01, 2023	BUY	$102.94 - $114.86 $44,881 - $50,078	436 Added 1.4%	31,636 $3.37 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $123,815 - $158,747	-1,416 Reduced 4.34%	31,200 $3.46 Million
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $109,043 - $122,498	1,290 Added 4.12%	32,616 $2.81 Million
Q2 2022 Jul 21, 2022	BUY	$83.49 - $94.64 $19,954 - $22,618	239 Added 0.77%	31,326 $2.86 Million
Q1 2022 May 04, 2022	BUY	$73.51 - $82.4 $12,496 - $14,008	170 Added 0.55%	31,087 $2.55 Million
Q4 2021 Feb 07, 2022	SELL	$72.28 - $90.54 $49,150 - $61,567	-680 Reduced 2.15%	30,917 $2.43 Million
Q3 2021 Oct 28, 2021	BUY	$71.68 - $78.83 $86,374 - $94,990	1,205 Added 3.96%	31,597 $2.37 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $200,805 - $222,111	2,856 Added 10.37%	30,392 $2.31 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $8,400 - $9,895	-122 Reduced 0.44%	27,536 $2.15 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $1.63 Million - $1.8 Million	-22,644 Reduced 45.02%	27,658 $2.07 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $1.62 Million - $1.83 Million	22,083 Added 78.26%	50,302 $3.98 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $69,997 - $79,649	994 Added 3.65%	28,219 $2.18 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $99,665 - $138,140	-1,573 Reduced 5.46%	27,225 $2.1 Million
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $57,719 - $65,129	-744 Reduced 2.52%	28,798 $2.62 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $55,766 - $60,787	-733 Reduced 2.42%	29,542 $2.49 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $15,644 - $18,276	-224 Reduced 0.73%	30,275 $2.54 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $136,863 - $156,101	-1,967 Reduced 6.06%	30,499 $2.54 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $70,067 - $81,312	-1,074 Reduced 3.2%	32,466 $2.48 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $11,538 - $13,568	-200 Reduced 0.59%	33,540 $2.38 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $7,421 - $8,719	-146 Reduced 0.43%	33,740 $2.05 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $1,019 - $1,184	20 Added 0.06%	33,886 $1.85 Million
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $1,496 - $1,787	29 Added 0.09%	33,866 $1.91 Million
Q3 2017 Oct 31, 2017	SELL	$58.67 - $63.13 $16,486 - $17,739	-281 Reduced 0.82%	33,837 $2.17 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,118	34,118 $2.19 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Merck & Co., Inc. Transaction History